Study on relapse prevention of Crohn's disease;Studien zur rezidivprophylaxe des morbus Crohn

Chirurg

Volumn 69, Issue 9, 1998, Pages 908-914

  Scholmerich J ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Crohn's disease; Drug treatment; Relapse

Indexed keywords

CLINICAL TRIAL; CROHN DISEASE; HUMAN; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REVIEW; TREATMENT OUTCOME;

CLINICAL TRIALS; CROHN DISEASE; HUMANS; POSTOPERATIVE COMPLICATIONS; RECURRENCE; TREATMENT OUTCOME;

EID: 0032150119     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001040050512     Document Type: Article

References (41)

1. Belluzzi A, Brignola C, Campieri M, Pera A, et al (1996) Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med 334: 1557
2. Best WR, Becktel JM, Singleton JW, Kern F jr. (1976) Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology 70: 439
3. Bouhnik Y, Lémann M, Mary JY, Scemama G, et al (1996) Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 347: 215
4. Brignola C, Campieri N, Farrugia P, et al (1988) The possible utility of steroids in the prevention of relapses of Crohn's disease in remission. A preliminary study. J Clin Gastroenterol 10: 631
5. Brignola C, Cottone M, Pera A, et al (1995) Mesalamine in the prevention of endoscopic recurrence after intestinal resection in Crohn's disease. Gastroenterology 108: 345
6. Cammà C, Giunta M, Rosseli M, Cottone M (1997) Mesalamine in the maintainance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. Gastroenterology 113: 1465
7. Caprilli R, Andreoli A, Capurso L, Corrao G, et al (1994) Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Aliment Pharmacol Ther 8: 35
8. D'Haens GR, Geboes K, Peeters M, Baert F, et al (1998) Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum. Gastroenterology 114: 262
9. De Franchis R, Omodei P, Ranzi T, Brignola C, et al (1997) Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease. Aliment Pharmacol Ther 11: 845
10. Ewe K (1995) Non-systemic steroids for relapse prevention in Crohn's disease. In: Tytgat GNJ, Bartelsman JFWM, van Deventer SJH (eds) Inflammatory bowel disease. Kluwer, Lancaster, p 666
11. Ewe K, Herfarth Ch, Malchow H, Jesdinsky HJ (1989) Postoperative recurrence of Crohn's disease in relation to radicality of operation and sulfasalazine prophylaxis. A multicenter trial. Digestion 42: 224
12. Feagan B, Greenberg GR, Löfberg R, Ferguson A, Persson T (1997) Budesonide controlled ileal release prolonged remission in Crohn's disease: metaanalysis. Gut [Suppl 3] 41: A17
13. Feagan B, Rochon J, Fedorak R, Irvine J, et al (1995) Methotrexate for the treatment of Crohn's disease. N Engl J Med 332: 292
14. Florent C, Cortot A, Quandale P, Sahmound T, et al (1996) Placebo-controlled clinical trial of mesalazine in the prevention of early endoscopic recurrences after resection for Crohn's disease. Groupe d,Etüdes Therapeutiques des Affections Inflammatoires Digestives (GETAID). Eur J Gastroenterol Hepatol 8: 229
15. Greenberg GR, Feagan BG, Martin F, Sutherland LR, et al (1996) Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group. Gastroenterology 110: 45
16. Gross V, Andus T, Ecker KW, et al (1995) Oral pH-modified release budesonide for maintenance of steroid induced remission in Crohn's disease - An interim analysis. Gastroenterology 108: A828
17. Hanauer S, Korelitz B, Rutgeerts P, Present D, Peppercorn M (1998) Postoperative prophylaxis with 6-MP, 5-ASA, or placebo in Crohn's disease: A 2 year multicenter trial. Gastroenterology 114: A1011
18. Hellers G, Löfberg R, Rutgeerts P, et al (1996) Oral budesonide for prevention of recurrence following ileocecal resection of Crohn's disease. A one year placebo-controlled study. Gastroenterology 110: A923
19. International Mesalazine Study Group (1990) Coated oral 5-aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease. Aliment Pharmocol Ther 4: 55
20. Lochs H, Mayer M, Fleig WE, Mortensen PB, Bauer P (1997) Prophylaxis of postoperative relapse in Crohn's disease with mesalazine (PENTASA) in comparison to placebo. Gastroenterology 112: A1027
21. Löfberg R, Rutgeerts P, Malchow H, Lamers C, et al (1996) Budesonide prolongs time to relapse in ileal and ileocaecal Crohn's disease. A placebo controlled one year study. Gut 39: 82
22. Lorenz-Meyer H, Bauer P, Nicolay C, Schulz B, et al (1996) Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multicenter trial. Study Group Members (German Crohn's Disease Study Group). Scand J Gastroenterol 31: 778
23. Malchow H, Ewe K, Brandes JW, et al (1984) European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatment. Gastroenterology 86: 249
24. McLeod RS, Wolff BG, Steinhart AH, et al (1995) Prophylactic mesalamine treatment decreases postoperative recurrence of Crohn's disease. Gastroenterology 109: 404
25. Messori A, Brignola C, Trallori G, et al (1994) Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: A meta-analysis. Am J Gastroenterol 89: 692
26. Modigliani R, Colombel JF, Dupas J-L, Dapoigny M, et al (1996) Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance. Gastroenterology 110: 688
27. Oren R, Moshkowitz M, Odes S, et al (1997) Methotrexate in chronic active Crohn's disease: a double blind randomized, Israeli multicenter trial. Am J Gastroenterol 92: 2203
28. Pearson DC, May GR, Pick GH, et al (1995) Azathioprine and 6-mercaptopurine in Crohn's disease. A meta-analysis. Ann Intern Med 123: 132
29. Riordan A, Hunter J, Cowan R, Crampton J, et al (1993) Treatment of active Crohn's disease with exclusion diet: east anglian multicenter controlled trial. Lancet 342: 1131
30. Rutgeerts P, d'Haens G, van Deventer SJH, Present DH, et al (1997) Retreatment with anti-TNF-(alpha) chimeric antibody (cA2) effectively maintains cA2-induced remission in Crohn's disease. Gasroenterology 112: A1078
31. Rutgeerts P, Geboes K, Vantrappen G, Beyls J (1990) Predictability of the postoperative course of Crohn's diesease. Gastroenterology 99: 956
32. Rutgeerts P, Hiele M, Geboes K, Peelers M, et al (1995) Controlled trial of metronidazol treatment for prevention of Crohn's recurrence after ileal resection. Gastroenterology 108: 1617
33. Salomon P, Kornbluth A, Aisenberg J, Janowitz HD (1992) How effective are current drugs for Crohn's disease? A metaanalysis. J Clin Gastroenterol 14: 211
34. Schölmerich J (1996) Therapie chronisch entzündlicher Darmerkrankungen. In: Gerok W, Hartmann F, Pfreundschuh M; Philipp T, Schuster H-P, Sybrecht GW (Hrsg) Klinik der Gegenwart, IV, 16. Urban & Schwarzenberg, München, 1
35. Schreiber S, Raedler A, Peters I (1997) Treatment with azathioprine and budesonide prevents reoccurence of ileocolonic stenoses after endoscopic dilatation. Gastroenterology 112: A1067
36. Stange EF, Schmid U, Fleig WE, Ditschuneit H (1990) Ausschlußdiät bei Morbus Crohn: Eine kontrollierte randomisierte Stude. Z Gastroenterol 28: 561
37. Steinhart AH, Hemphill DJ, Greenberg GR (1994) Sulfasalazine und mesalazine for the maintenance therapy of Crohn's disease: A metaanalysis. Am J Gastroenterol 89: 2116
38. Sutherland LR, Martin F, Bailey RJ, Fedorak RN, et al (1997) A randomized, placebo-controlled, double-blind trial of Mesalamine in the maintenance of remission of Crohn's disease. Gastroenterology 112: 1069
39. Sutherland LR, May GR, Shaffer EA (1993) Sulfasalazine revisited: A meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 118: 540
40. Thomson ABR, Wright JP, Vatn M, et al (1995) Mesalazine (Mesasal/Claversal) 1.5 g bid daily versus placebo in the maintenance of remission of patients with Crohn's disease. Aliment Pharmacol Ther 9: 673
41. Vermeire S, Rutgeerts P (1998) Medikamentöse Prophylaxe des M. Crohn-Rezidivs im neoterminalen Ileum nach ileokolischer Resektion. Zentralbl Chir 123: 352